TY  - CONF

T1  - Dupilumab efficacy and safety up to 2years in children aged 6months to 5years with atopic dermatitis

JO  - AUSTRALASIAN JOURNAL OF DERMATOLOGY

PY  - 2025/06/01

AU  - Su J

AU  - Paller AS

AU  - Simpson E

AU  - Siegfried EC

AU  - Cork MJ

AU  - Arkwright P

AU  - Pinter A

AU  - Dubost-Brama A

AU  - Chen Z

AU  - Bansal A

AU  - Prescilla R et al

ED  - 

VL  - 66

Y2  - 2025/12/21

ER  -